tiprankstipranks

Daniel Abdun-Nabi Insider Profile

11 Followers
Daniel Abdun-Nabi, Director at Aptevo Therapeutics, holds 400.00 shares in Aptevo Therapeutics (Ticker: APVO), holds 144.55K shares in Emergent Biosolutions (Ticker: EBS), holds ― shares in RegenXBio (Ticker: RGNX).
tipranks
Daniel Abdun-Nabi

Daniel Abdun-Nabi
Aptevo Therapeutics (APVO)
Director

Ranked #38,973 out of 109,030 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+9.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$923K
99.92%
0.08%
0.00%
A breakdown of Daniel Abdun-Nabi's holdings

Insider Roles

Emergent Biosolutions
(EBS)
CEO, Director
Aptevo Therapeutics
(APVO)
Director
RegenXBio
(RGNX)
Director
Roles that Daniel Abdun-Nabi holds in companies

Most Profitable Insider Trade

Stock:
Emergent Biosolutions
(EBS)
Rating:Informative Buy
Date:Dec 29, 2014 - Dec 29, 2015
Return:+45.10%
The most profitable trade made by Daniel Abdun-Nabi

Daniel Abdun-Nabi's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Aptevo Therapeutics
Aug 10, 2026
Director
Uninformative Buy
1.63K
$720.00
Emergent Biosolutions
Mar 04, 2019
CEO, Director
Uninformative Sell
846.23K
$922.25K
RegenXBio
Director
List of latest transactions for each holding click on a transaction to see Daniel Abdun-Nabi's performance on stock

Daniel Abdun-Nabi insider profile FAQ

What is the percentage of profitable transactions made by Daniel Abdun-Nabi?
The percentage of profitable transactions made by Daniel Abdun-Nabi is 67%.
    What is the average return per transaction made by Daniel Abdun-Nabi?
    The average return per transaction made by Daniel Abdun-Nabi is 9.80%.
      What stocks does Daniel Abdun-Nabi hold?
      Daniel Abdun-Nabi holds: APVO, EBS, RGNX stocks.
        What was Daniel Abdun-Nabi’s latest transaction?
        Daniel Abdun-Nabi latest transaction was an Uninformative Buy of $1.63K.
          What was Daniel Abdun-Nabi's most profitable transaction?
          Daniel Abdun-Nabi’s most profitable transaction was an Informative Buy of EBS stock on December 29, 2014. The return on the trade was 45.10%.
            What is Daniel Abdun-Nabi's role in Aptevo Therapeutics?
            Daniel Abdun-Nabi's role in Aptevo Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.